Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Topical ruxolitinib: A new treatment for vitiligo
Gianluca Tavoletti, Gianluca Avallone, Claudio Conforti, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 11, pp. 2222-2230
Open Access | Times Cited: 21

Showing 21 citing articles:

Transcutaneous Auricular Vagus Nerve Stimulation Alleviates Monobenzone-Induced Vitiligo in Mice
Shiqi Luo, Xinghua Meng, Jing Ai, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3411-3411
Open Access | Times Cited: 5
Role of Cytokines and Chemokines in Vitiligo and Their Therapeutic Implications
Marcelina Kądziela, Magdalena Kutwin, Paulina Karp, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4919-4919
Open Access | Times Cited: 5
Treatment advances in Vitiligo: An Updated Review
Ishrat Binti Ismail, Yasmeen Jabeen Bhat, Mohd Shurjeel Ul Islam
Dermatology Practical & Conceptual (2025) Vol. 15, Iss. 1, pp. 4600-4600
Open Access
A Review on the Mechanisms and Clinical Advances of JAK Inhibitors in the Treatment of Rosacea
Yulian Hu, Biyu Li, HU Ren-ming, et al.
Journal of Cutaneous Medicine and Surgery (2025)
Closed Access
Metabolic anomalies in vitiligo: a new frontier for drug repurposing strategies
Alessia Paganelli, Federica Papaccio, Mauro Picardo, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Segmental Vitiligo: Rapid Spread From a Halo Nevus
Monica Z Trevino, Jodie Shao, Elene Valladares, et al.
Cureus (2025)
Open Access
Updates on Potential Therapeutic Approaches for Vitiligo: Janus Kinase Inhibitors and Biologics
Valentina Pala, Simone Ribero, Pietro Quaglino, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7486-7486
Open Access | Times Cited: 8
Biologic drugs induced vitiligo: case reports and review of literature
Xinyi Shao, Tingqiao Chen, Xingyu Pan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Vitiligo Treated with Combined Piperine-Based Topical Treatment and Narrowband Ultraviolet B Therapy: Follow-Up with Reflectance Confocal Microscopy
Cristina Bertoli, Johanna Chester, Chiara Cortelazzi, et al.
Diagnostics (2024) Vol. 14, Iss. 5, pp. 494-494
Open Access | Times Cited: 1
New Therapeutic Targets in Vitiligo
Marcelina Kądziela, Magdalena Kutwin, Paulina Karp, et al.
(2024)
Open Access | Times Cited: 1
JAK Inhibitors in Immune Regulation and Treatment of Vitiligo
Kewei Liu, Linyi Zhou, Meihui Shi, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 80, pp. 87-96
Closed Access | Times Cited: 1
Exploring the Role of Adipose Tissue Dysregulation in Vitiligo Pathogenesis: A Body Composition Analysis
Xinyi Shao, Xingyu Pan, Tingqiao Chen, et al.
Acta Dermato Venereologica (2024) Vol. 104, pp. adv41018-adv41018
Open Access | Times Cited: 1
Recent trends in the treatment of vitiligo using novel drug delivery system
Nandita Sahu, Parag Jain, Deepika Sahu, et al.
International Journal of Pharmaceutics (2024), pp. 125106-125106
Closed Access | Times Cited: 1
Recent advance of small-molecule drugs for clinical treatment of multiple myeloma
Jianhui Zhao, Qin-Li Xu, Shuai Ma, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115492-115492
Closed Access | Times Cited: 3
Short-Term (24 Weeks) Treatment Efficacy and Safety of Ruxolitinib Cream in Participants with Vitiligo: A Systematic Review and Meta-Analysis
Yuan Yuan, Li Zheng, Shaohua Yu, et al.
Research Square (Research Square) (2024)
Open Access
Short-term (24 weeks) treatment efficacy and safety of ruxolitinib cream in participants with vitiligo: a systematic review and meta-analysis
Yuan Yuan, Yatong Zhang, Li Zheng, et al.
Systematic Reviews (2024) Vol. 13, Iss. 1
Open Access
A pilot study of tofacitinib citrate with 308-nm excimer laser for the treatment of vitiligo
Jia Gao, Q. Li, H.C. Huang, et al.
Clinical and Experimental Dermatology (2024)
Closed Access
Vitiligo: Unmet Need, Management and Treatment Guidelines
Angelo Valerio Marzano, Silvia Alberti Violetti, Carlo Alberto Maronese, et al.
Dermatology Practical & Conceptual (2023), pp. e2023316S-e2023316S
Open Access | Times Cited: 1
Decreased Neutrophil-to-lymphocyte Ratio in Patients with Vitiligo: National Data Analysis
Sarah Weissmann, Amit Shira Babyev, Michal Gordon, et al.
Acta Dermato Venereologica (2024) Vol. 104, pp. adv35406-adv35406
Open Access
Vitiligo, it was about time!
Thierry Passeron
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 11, pp. 2155-2156
Open Access
Advances in the use of Ruxolitinib in the treatment of vitiligo disease
Florencia Monteforte, Javier González‐Argote
Salud Ciencia y Tecnología - Serie de Conferencias (2023) Vol. 2, pp. 324-324
Open Access
Page 1

Scroll to top